Funded by the NIH HEAL Initiative℠
This project will develop models to predict individual patient’s risk for relapse (or dropout from treatment) when treated with medications for OUD including methadone, buprenorphine, or extended-release depot naltrexone.
Sean Luo, MD, Ph.D.
1051 Riverside Drive, Unit 66
New York, NY 10033
Daniel J. Feaster, Ph.D.
1120 NW 14th Street, Suite 1059
Miami, FL 33136